Streptogramin and related antibiotics are mixtures of two compounds,A
and B (e.g. Dalfopristin and Quinupristin), particularly against Gram-
positive bacteria. Staphylococci resistant to these mixtures are alway
s resistant to the A compounds but are not necessarily resistant to th
e B compounds. Resistance to A compounds and to the mixtures is confer
red by acetyltransferases or ATP-binding proteins via unknown mechanis
ms. Several genes encoding each of the two categories of protein have
been characterized and regularly detected on plasmids. Genes encoding
lactonases, which inactivate B compounds,have been occasionally detect
ed on these plasmids. Staphylococci which harbour plasmids conferring
resistance to A compounds should not be treated with the mixtures even
if they appear susceptible in vitro. Indeed, susceptibility to the mi
xtures of staphylococci carrying resistance to A compounds has often b
een attributed to partial loss of the plasmids conferring this resista
nce. When staphylococci are constitutively resistant to B compounds, t
he in vitro activities of the mixtures should be evaluated, because th
ey are better correlated than MICs with their efficacy in therapy.